Portable Motor Rehab Device To Improve Arm Movement After Stroke
Funder
National Health and Medical Research Council
Funding Amount
$241,064.00
Summary
One in six people have a stroke at some time in their life. Half the people with upper limb problems after stroke do not recover useful function. New technologies are needed to improve outcomes. This project develops the portable Arm Movement Measurement device, which measures motor control of the arm and hand for clinicians and patients, to improve rehabilitation outcomes, and for researchers to use to measure motor control in clinical studies.
Development Of A Humanised Antibody For Treatment Of Cancer And Stroke
Funder
National Health and Medical Research Council
Funding Amount
$242,800.00
Summary
This grant explores the ability of novel monoclonal antibodies to inhibit cancer cell growth, and to prevent complications in patients with brain injuries. The results of this work will enable the development of new strategies for antibody-based therapy of many types of cancer, and improve outcomes in patients suffering from acute stroke.
Development Of A Catheter-based Device For The Detection Of Vulnerable Atherosclerotic Plaques
Funder
National Health and Medical Research Council
Funding Amount
$560,582.00
Summary
Atherosclerosis (hardening of blood vessels) is a major cause of disability and death worldwide. These lesions can suddenly become unstable leading to rupture and the occlusion of blood vessels with catastrophic complications such as heart attacks and strokes. Our project aims to develop a novel invasive imaging system to reliably detect these unstable lesions before they cause complications so that preventive measures can be taken, potentially saving many lives.
Developing A Prototype Of A Next Generation Brain Computer Interface
Funder
National Health and Medical Research Council
Funding Amount
$837,398.00
Summary
Persons affected by quadriplegia and hemiplegia from stroke and spinal cord injury have few treatment options. Brain Machine Interfaces reconnect brain to a prosthetic limb, bypassing damaged nervous system. Our group has developed a BMI that can be implanted minimally-invasively, inside a blood vessel in the brain. We propose to manufacture a world-first device for a human clinical trial pilot study. The aim is to restore mechanical control over the physical environment for a paralysed patient.
Development Of A Take-home Rehabilitation Device That Improves Visual Stability And Balance In Patients With Peripheral Vestibular Injury
Funder
National Health and Medical Research Council
Funding Amount
$789,377.00
Summary
The balance system senses head motion via the balance organs, one in each inner ear, and stabilises vision during head movements. Without it, every time you walk, run, or drive on a bumpy road, the world appears to bounce. We have developed a device shown to reliably 'train up' the balance system. Our aim is to develop this device further for effective take-home rehabilitation.
Preclinical Development Of Q2361, A Transforming New Drug For Skin Cancer Prevention In Organ Transplant Recipients
Funder
National Health and Medical Research Council
Funding Amount
$724,957.00
Summary
Patients that receive organ transplants need additional medications in order to prevent organ rejection. Unfortunately, these drugs carry an unwanted side-effect - they permit the development of skin cancer. Currently, other than surgery, little can be done to help these patients. Our preliminary data suggest that a new drug may prevent these skin cancers from forming. This project aims to deliver key insights into the influence of this drug and its role in skin cancer prevention.
A portable device that can measure glycosylated haemoglobin (HbA1c) in the home will be developed. HbA1c is an important biomarker of the average blood glucose levels over the preceding three months and hence guides a diabetic regarding their blood glucose treatment regime. A 1% decrease in HbA1c levels is associated with a dramatic decrease in chronic health complications from diabetes. The HbA1c meter that will be developed will be able to operate with existing glucose meter technologies.
The aim of this proposal is to test the safety of a novel immunotherapy based on Helicobacter pylori platform technology to treat childhood allergies. Repeated oral administration of killed H. pylori mimics colonisation in the stomach and assists the development of a balanced immune system without the associated disease risk of live H. pylori. To achieve this goal Professor Barry Marshall has assembled a cross-disciplinary team of experts from Industry, Academia and Clinic.
Development Of A Blood-based Screening Test For Colorectal Neoplasia; Biomarker Expression In Circulating Tumor Cells And Tumor-derived Microvesicles
Funder
National Health and Medical Research Council
Funding Amount
$513,938.00
Summary
A blood-based test for bowel cancer and the premalignant lesion (i.e. adenomas) has potential to improve several aspects of screening for bowel cancer – improved capacity to detect lesions in well people who do not suspect their presence, avoidance of faecal sampling and fewer false-positive results. There is no reliable simple screening test for adenomas. This study aims at developing a practical blood test based on a device that filters and enriches cells from blood that carry these markers